Biomarkers for paediatric TB. (360G-Wellcome-078116_Z_05_Z)
There is an urgent need for new diagnostic methods for TB in children. In a pilot study, funded by the Wellcome Trust, we have found 4 serum protein biomarkers that discriminate between culture positive proven cases of paediatric TB from other infections/inflammatory conditions with a sensitivity and specificity of 92.3% and 94.3% respectively. With a view to developing a point of care (POC) test, we will identify the 4 biomarkers at the molecular level and determine whether they can be detected at sufficient sensitivity by immunological means. If so, then a POC test with great potential to save children's lives can be developed with confidence. Specifically our aims are:(1) The molecular identification of 4 serum biomarkers specific for paediatric TB that we have found in a cohort of Cape Town (South African) children.(2) Confirmation of biomarker identity by immunological and/or biochemical means.(3) Validation of biomarkers by ELISA as an initial step in developing an immunological based POC test for use in resource poor countries.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 110094 |
Applicant Surname | Langford |
Approval Committee | Immunology and Infectious Disease Funding Committee |
Award Date | 2005-10-25T00:00:00+00:00 |
Financial Year | 2005/06 |
Grant Programme: Title | Project Grant |
Internal ID | 078116/Z/05/Z |
Lead Applicant | Prof Paul Langford |
Other Applicant(s) | Prof Michael Levin |
Partnership Value | 110094 |
Planned Dates: End Date | 2007-06-30T00:00:00+00:00 |
Planned Dates: Start Date | 2006-01-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | Greater London |